2012
DOI: 10.1128/jcm.06275-11
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Detection of Campylobacter jejuni as a Cause of Culture-Negative Spondylodiscitis

Abstract: Spondylodiscitis caused by Campylobacter species is a rare disease which is most often caused by Campylobacter fetus. We report a case of culture-negative spondylodiscitis and a psoas abscess due to Campylobacter jejuni in a 68-year-old woman, as revealed by 16S rRNA gene and Campylobacter-specific PCRs from biopsied tissue. CASE REPORT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 9 publications
(20 reference statements)
0
5
0
Order By: Relevance
“…The results of our AST were in coherence with overall resistance patterns for C. jejuni in Denmark, where resistance to ciprofloxacin is reported in almost half of domestically acquired human C. jejuni cases [ 23 ]. In previous case reports with C. jejuni spondylodiscitis, treatment has consisted of fluoroquinolones, macrolides or carbapenems, for a total duration of 5–10 weeks [ 24 , 25 ]. While imipenem is commonly utilized in several countries, meropenem serves as the predominant carbapenem of choice in Denmark and was selected as the primary treatment for our patient in this case.…”
Section: Discussionmentioning
confidence: 99%
“…The results of our AST were in coherence with overall resistance patterns for C. jejuni in Denmark, where resistance to ciprofloxacin is reported in almost half of domestically acquired human C. jejuni cases [ 23 ]. In previous case reports with C. jejuni spondylodiscitis, treatment has consisted of fluoroquinolones, macrolides or carbapenems, for a total duration of 5–10 weeks [ 24 , 25 ]. While imipenem is commonly utilized in several countries, meropenem serves as the predominant carbapenem of choice in Denmark and was selected as the primary treatment for our patient in this case.…”
Section: Discussionmentioning
confidence: 99%
“…The optimal treatment has not yet been defined for CF infective spondylodiscitis, although erythromycin and fluoroquinolones are the recommended treatment for systemic campylobacteriosis ( 5 , 14 ). Nevertheless, it is paramount to accurately identify the causative pathogen in order to effectively prescribe targeted antimicrobial therapy and to select antibiotics that have good tissue penetration for such infections ( 5 ).…”
Section: Discussionmentioning
confidence: 99%
“…Though erythromycin and fluoroquinolones are the recommended treatment for systemic campylobacteriosis [13], optimal treatment has not yet been defined for C. fetus infective spondylodiscitis.…”
Section: Discussionmentioning
confidence: 99%
“…Though erythromycin and fluoroquinolones are the recommended treatment for systemic campylobacteriosis [ 13 ], optimal treatment has not yet been defined for C. fetus infective spondylodiscitis. However, it is always important to select antibiotics that have good tissue penetration for such infections.…”
Section: Discussionmentioning
confidence: 99%